You have 9 free searches left this month | for more free features.

MMRd

Showing 1 - 22 of 22

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Epigenetic MMRd in Endometrial carcinomas-a Real World Study

Not yet recruiting
  • Endometrial Neoplasms
    • (no location specified)
    Nov 17, 2022

    Endometrial Cancer Trial (Anlotinib + Camrelizumab)

    Not yet recruiting
    • Endometrial Cancer
    • Anlotinib + Camrelizumab
    • (no location specified)
    Sep 26, 2022

    Endometrial Cancer Trial in Worldwide (drug, radiation, other)

    Recruiting
    • Endometrial Cancer
    • Toronto, Canada
    • +5 more
    Jul 12, 2022

    Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

    Recruiting
    • Colorectal Neoplasms
    • Microsatellite Instability
    • temozolomide (induction),
    • pembrolizumab (treatment)
    • Milano, Italy
    • +3 more
    Sep 28, 2022

    Immunodeficiency Trial in Charlotte (Infusion of donor lymphocytes)

    Terminated
    • Immunodeficiency
    • Infusion of donor lymphocytes
    • Charlotte, North Carolina
      Levine Children's Hospital, Carolinas Medical Center
    Apr 20, 2022

    Metastatic Castration-Resistant Prostate Cancer Trial in United States (XmAb20717 + carboplatin + cabazitaxel, XmAb20717 +

    Recruiting
    • Metastatic Castration-Resistant Prostate Cancer
    • XmAb20717 + carboplatin + cabazitaxel
    • +2 more
    • Duarte, California
    • +9 more
    May 24, 2022

    Biochemically Recurrent Prostate Carcinoma, Prostate Adenocarcinoma Trial in Seattle (biological, drug, other)

    Recruiting
    • Biochemically Recurrent Prostate Carcinoma
    • Prostate Adenocarcinoma
    • Durvalumab
    • +3 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Jan 26, 2023

    Multiple Myeloma Minimal Residual Disease

    Completed
    • Multiple Myeloma
    • blood samples and bone marrow aspirates will be collected
    • Lille, France
    • +2 more
    Sep 2, 2022

    Ovarian Tumors, Endometrial Tumors, Uterine Cervical Tumors Trial (Dostarlimab, Bevacizumab, Doxorubicin)

    Not yet recruiting
    • Ovarian Neoplasms
    • +5 more
    • (no location specified)
    Sep 3, 2023

    Staging Endometrial caNcer Based on molEcular ClAssification

    Recruiting
    • Endometrial Cancer
    • +2 more
      • Pamplona, Navarra, Spain
        Clinica Universidad de Navarra
      Jan 30, 2023

      Pancreatic Cancer Trial in Goyang-si

      Active, not recruiting
      • Pancreatic Cancer
        • Goyang-si, Gyeonggi-do, Korea, Republic of
          NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
        Sep 27, 2022

        Pancreatic Cancer Trial (Pembrolizumab, Olaparib)

        Not yet recruiting
        • Pancreatic Cancer
        • (no location specified)
        Oct 21, 2021

        Endometrial Tumors, Endometrial Cancer Trial in Seoul (Nivolumab)

        Not yet recruiting
        • Endometrial Neoplasms
        • Endometrial Cancer
        • Seoul, Korea, Republic of
          Severance Hospital, Yonsei University Health System
        Mar 21, 2023

        Endometrial Cancer Trial (Paclitaxel, Carboplatin, Cisplatin)

        Not yet recruiting
        • Endometrial Cancer
        • (no location specified)
        Aug 4, 2022

        Adenocarcinoma - GEJ, Cancer of Esophagus Trial in Cambridge (Temozolomide, Temozolomide 50mg/m2/day, Temozolomide 3 month)

        Recruiting
        • Adenocarcinoma - GEJ
        • Cancer of Esophagus
        • Cambridge, Cambridgeshire, United Kingdom
          Cambridge University Hospitals NHS Foundation Trust
        Oct 6, 2021

        Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Frankfurt, Bern (Atezolizumab, 5-Fluorouracil, Calciumfolinat)

        Active, not recruiting
        • Gastric Cancer
        • Gastroesophageal Junction Adenocarcinoma
        • Frankfurt, Germany
        • +1 more
        Apr 14, 2022

        A Retrospective Study on Multiple Classifier Endometrial Cancer

        Recruiting
        • Uterine Cancer
        • Observation only
        • Milan, Italy
          Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
        Jul 27, 2023

        Endometrial Cancer Trial in Vancouver (Treatment de-escalation)

        Recruiting
        • Endometrial Cancer
        • Treatment de-escalation
        • Vancouver, British Columbia, Canada
          BC Cancer - Vancouver Centre
        Mar 1, 2022

        Analysis of miRNA Expression in Endometrial Cancer

        Recruiting
        • Endometrial Cancer
          • Bologna, Bo, Italy
            IRCCS- Azienda Ospedaliera-Universitaria di Bologna
          Jul 19, 2022

          Endometrial Tumors, Uterine Tumors, Endometrium Cancer Trial in Netherlands (PARP inhibitor and Anti-PD-L1)

          Active, not recruiting
          • Endometrial Neoplasms
          • +2 more
          • PARP inhibitor and Anti-PD-L1
          • Amsterdam, Netherlands
          • +7 more
          Mar 30, 2021

          Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chapel Hill (biological, drug, procedure)

          Completed
          • Chronic Myeloproliferative Disorders
          • +4 more
          • anti-thymocyte globulin
          • +8 more
          • Chapel Hill, North Carolina
            Lineberger Comprehensive Cancer Center at University of North Ca
          May 23, 2017

          Chronic Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Chapel Hill (biological, drug, procedure)

          Completed
          • Chronic Myeloproliferative Disorders
          • +4 more
          • rabbit anti-thymocyte globulin (ATG)
          • +7 more
          • Chapel Hill, North Carolina
            Lineberger Comprehensive Cancer Center at University of North Ca
          Jun 16, 2017